Close this search box.

We are creating some awesome events for you. Kindly bear with us.

Digital Solutions for Medication Management

Getting your Trinity Audio player ready...

A collaborative research initiative at the University of Queensland, in partnership with Brisbane’s Princess Alexandra Hospital (PAH), aims to mitigate the risks associated with medication for both inpatients and those transitioning from hospital to their homes.

Dr Nazanin Ghahreman-Falconer, an expert from UQ’s School of Pharmacy, is spearheading this innovative project, leveraging digital hospital technologies to enhance medication management for inpatients and reduce rehospitalisation rates attributable to medication-related harm.

The pressing health challenge of rehospitalisation has become a focal point of this endeavour, particularly in Queensland, where as many as 25% of adult patients are readmitted within a mere 28 days after their initial discharge.

The vulnerability that patients face post-hospitalisation, combined with potential confusion surrounding their medications, poses substantial risks, including falls, bleeding, and rehospitalisation. A notable statistic underscores the gravity of the situation: approximately 90% of patients experience alterations in their medication regimens while in the hospital, which can lead to complications if not communicated clearly to the patients and their healthcare providers.

Beyond the immediate adverse consequences for patients, rehospitalisation places a significant burden on the healthcare system. Thus, the overarching goal of this research collaboration is to devise effective solutions to mitigate this challenge.

Dr Ghahreman-Falconer, in conjunction with Associate Professor Michael Barras from PAH, is actively engaged in the RECARD Study. This study employs predictive modelling to proactively prevent rehospitalisation following a heart attack. At its core, the RECARD Study involves the development of digital tools aimed at aiding clinicians in identifying cardiac patients who are at the highest risk of being readmitted due to medication-related harm.

The research is characterised by its emphasis on identifying and supporting the most vulnerable patients, including those from Aboriginal and Torres Strait Islander communities. The initial phase of the project entails extensive consultation with community stakeholders to construct a predictive model for identifying individuals at risk of rehospitalization. Simultaneously, a toolkit is being developed to facilitate tailored medication management and support during the critical period of patient discharge.

Another noteworthy project in collaboration with PAH harnesses the power of hospital data and artificial intelligence (AI) to pinpoint patients susceptible to medication-related harm, allowing for early and targeted interventions during their hospital stay.

Dr Ghahreman-Falconer highlighted the previous research accomplishment of creating a model for dosing high-risk medications, such as heparin, a commonly used anticoagulant. Accurate dosing of heparin is notoriously challenging but critical for patient safety.

Building on this prior success, the team is currently developing an app that will be integrated into the hospital’s electronic systems. This app aims to provide guidance to doctors when prescribing intravenous heparin, enhancing precision and safety in medication management.

The incorporation of such innovative digital tools promises to empower clinicians to work more efficiently, ensuring timely and targeted care for those who need it most. These advancements are poised to yield better and safer health outcomes for patients across the healthcare spectrum.

Dr Ghahreman-Falconer’s remarkable contributions to this collaborative research endeavour have earned recognition in UQ’s prestigious 2023 Research and Innovation Week awards. This recognition underscores the significance and potential impact of this work in revolutionising medication management practices, reducing rehospitalisation rates, and improving overall patient well-being. The fusion of cutting-edge technology and healthcare expertise exemplified in this research holds promise for transforming healthcare delivery and patient outcomes, not only in Queensland but potentially on a broader scale as well.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


As a Titanium Black Partner of Dell Technologies, CTC Global Singapore boasts unparalleled access to resources.

Established in 1972, we bring 52 years of experience to the table, solidifying our position as a leading IT solutions provider in Singapore. With over 300 qualified IT professionals, we are dedicated to delivering integrated solutions that empower your organization in key areas such as Automation & AI, Cyber Security, App Modernization & Data Analytics, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Renowned for our consulting expertise and delivering expert IT solutions, CTC Global Singapore has become the preferred IT outsourcing partner for businesses across Singapore.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.